Looking forward

Over the coming years the in-house production strategy will continue. There are currently no significant capacity constraints; therefore, we will continue to pursue profitable third party business.

We will continue to support new product development and the increasingly important product pipeline. Manufacturing will also continue to maximize effectiveness and efficiency and improve productivity whilst constantly adapting our quality, health and safety and environmental systems.

Looking forward for getting customers for contract manufacturing and third party manufacturing.

Looking forward for getting exporter of pharmaceutical products, under contract manufacturing and third party basis.

Looking forward for getting customer responses from foreign countries, hence we can offer wide range of products and ready for develop products on demand.